An Observational Safety Follow Up Trial Of The Occurrence Of Major Cardiovascular Events And All Cause Mortality In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Clinical Trials.

Trial Profile

An Observational Safety Follow Up Trial Of The Occurrence Of Major Cardiovascular Events And All Cause Mortality In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Clinical Trials.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 03 Jan 2008

At a glance

  • Drugs Torcetrapib/atorvastatin (Primary)
  • Indications Coronary disorders; Hyperlipidaemia; Hyperlipoproteinaemia type III; Hypertriglyceridaemia; Lipid metabolism disorders
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 03 Jan 2008 Status changed from recruiting to discontinued.
    • 07 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top